| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TScan Therapeutics, Inc. | Chief Legal and Strategy Officer | Voting Common Stock | 4.72K | $27.3K | $5.78 | Aug 23, 2024 | Direct |
| TScan Therapeutics, Inc. | Chief Legal and Strategy Officer | Stock Option (Right to Buy) | 366K | Aug 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | Aug 23, 2024 | 9 | -$421K | 4 | Aug 27, 2024 | Chief Legal and Strategy Officer |
| TCRX | TScan Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Chief Legal Officer |
| TCRX | TScan Therapeutics, Inc. | Feb 2, 2023 | 1 | $0 | 4 | Feb 6, 2023 | Chief Legal Officer |
| TCRX | TScan Therapeutics, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Jul 27, 2022 | Chief Legal Officer |
| TCRX | TScan Therapeutics, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Legal Officer |
| TCRX | TScan Therapeutics, Inc. | Sep 23, 2021 | 1 | $35.3K | 4 | Sep 27, 2021 | Chief Legal Officer |
| TCRX | TScan Therapeutics, Inc. | Sep 7, 2021 | 1 | $0 | 4 | Sep 9, 2021 | Chief Legal Officer |
| TCRX | TScan Therapeutics, Inc. | Sep 7, 2021 | 0 | $0 | 3 | Sep 9, 2021 | Chief Legal Officer |